LifeKnight Appoints Dr. Thomas Osborne as Lead Advisor for AI Innovation

August 19, 2025
LifeKnight, Inc. has appointed Dr. Thomas Osborne as Lead Advisor for Strategic Innovation to enhance its AI-powered safety and healthcare solutions.

LifeKnight, Inc. has appointed Dr. Thomas Osborne as Lead Advisor for Strategic Innovation, announced in a press release. Dr. Osborne, a recognized expert in clinical transformation and digital health, will guide the company's expansion of its AI-enabled safety and health platform. This platform focuses on real-time detection, prevention, and care across senior living, home health, and workforce safety sectors.

Dr. Osborne's appointment is a significant step for LifeKnight as it scales its technology to improve care and reduce costs. His role will involve leveraging AI to anticipate and prevent emergencies, rather than just reacting to them. This aligns with LifeKnight's mission to deliver intelligent, always-on safety infrastructure.

Avery Piantedosi, CEO of LifeKnight, expressed enthusiasm about Dr. Osborne's leadership, noting his success in digital transformation and innovation. Dr. Osborne also serves as Chief Medical Officer for Microsoft Federal and as an adjunct Clinical Professor at Stanford School of Medicine, bringing a wealth of experience to his new advisory role at LifeKnight.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

11/19
Deloitte Names Impiricus Fastest-Growing Company in 2025 Technology Fast 500
11/14
OpenAI Leads $15M Seed Round for Biosecurity Startup Red Queen Bio
11/13
MIT Technology Review Insights and Globant Report Rapid Agentic AI Uptake in Pharma
11/12
Diversis Capital Merges Genesis Automation Healthcare, Kermit, and Meperia
11/12
AI CoLab Hosts Second Annual 'AI for Health' Summit in Washington

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Market report

AI’s Time-to-Market Quagmire: Why Enterprises Struggle to Scale AI Innovation

ModelOp

The 2025 AI Governance Benchmark Report by ModelOp provides insights from 100 senior AI and data leaders across various industries, highlighting the challenges enterprises face in scaling AI initiatives. The report emphasizes the importance of AI governance and automation in overcoming fragmented systems and inconsistent practices, showcasing how early adoption correlates with faster deployment and stronger ROI.

Read more

You May Also Like